As of May 2024, the Hong Kong market is experiencing a notable upswing, with the Hang Seng Index climbing 2.64% recently, reflecting positive investor sentiment amid recovery hopes fueled by robust holiday spending and trade data. This buoyant backdrop sets an intriguing stage for examining growth companies in Hong Kong that boast high insider ownership—a factor often linked with strong corporate governance and aligned interests between shareholders and management.
/PRNewswire/ Adicon Holdings Limited (the "Company" or "Adicon"), one of the largest independent clinical laboratory (ICL) service providers listed on the.
Collaboration will provide biopharmaceutical companies access to Guardant Health's broad portfolio of cancer tests to help advance drug development programs and their clinical trials SINGAPORE
Carlyle-backed Chinese firm Adicon bags $88m funding from Khazanah, others
January 26, 2021
Adicon Holdings Limited, an independent clinical laboratory in China backed by US global investment firm Carlyle, on Tuesday announced the completion of an $88 million funding round that will help it speed up its diagnostic testing business in the country.
The latest round, which had reached its first close late last year, was led by Malaysia’s sovereign wealth fund Khazanah Nasional Berhad with the participation of Korean investment firm Mirae Asset Global Investments.
A host of healthcare driven investors including OrbiMed, Lake Bleu Capital, and Cenova Capital participated in the round.